Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.46.12.3797-3801.2002PMID 12435679PMCID PMC132781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Terbinafine

  2012cited by this paper
• [The management of onychomycosis].

  2003cited by this paper
• Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.

  2002cited by this paper
• In Vivo Fungicidal Effect of KP‐103 in a Guinea Pig Model of Interdigital Tinea Pedis Determined by Using a New Method for Removing the Antimycotic Carryover Effect

  2002influential reference
• KP‐103, a Novel Triazole Derivative, Is Effective in Preventing Relapse and Successfully Treating Experimental Interdigital Tinea Pedis and Tinea Corporis in Guinea Pigs

  2002influential reference
• In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs

  2001cited by this paper
• Itraconazole: an effective oral antifungal for onychomycosis

  2001cited by this paper
• Itraconazole: an effective oral antifungal for onychomycosis.

  2001cited by this paper
• Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.

  2000cited by this paper
• A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis

  2000cited by this paper
• Onychomycosis: current treatment and future challenges

  1999influential reference
• Management of Onychomycoses

  1999cited by this paper
• Current Topics in Diagnosis and Treatment of Tinea Unguium in Japan

  1999cited by this paper
• Synthesis and antifungal activities of (2R,3R)-2-aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives as topical antifungal agents.

  1999cited by this paper
• Drug interactions with itraconazole, fluconazole, and terbinafine and their management.

  1998cited by this paper
• A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication.

  1997cited by this paper
• Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.

  1997cited by this paper
• [Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp].

  1995cited by this paper
• Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.

  1995cited by this paper
• Kinetics of amorolfine in human nails

  1993cited by this paper
• Studies on the Affinity of Terbinafine with Keratine

  1993cited by this paper
• Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs

  1993cited by this paper
• Special features of the clinical use of oral terbinafine in the treatment of fungal diseases

  1992cited by this paper
• Short term treatment of dermatophyte onychomycosis with terbinafine.

  1992cited by this paper
• A randomized treatment duration‐finding study of terbinafine in onychomycosis

  1992cited by this paper
• Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin.

  1992cited by this paper
• [Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].

  1991cited by this paper
• [In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].

  1991cited by this paper
• Nail matrix kinetics of systemic terbinafine in onychomycosis

  1990cited by this paper
• Determination of terbinafine in nail samples during systemic treatment for onychomycoses

  1990cited by this paper
• Pharmacokinetics of Antimycotics with Emphasis on Local Treatment

  1988cited by this paper
• Antifungal activity of the allylamine derivative terbinafine in vitro

  1987cited by this paper
• In vivo antimycotic activity of naftifine

  1981cited by this paper

• Transfersome enhances nail penetration of antifungal drug and photosensitizer for chemo-photodynamic therapy of onychomycosis in a novel rat model.

  2025cites this paper
• Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis

  2024cites this paper
• Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals

  2023cites this paper
• Evaluation of Topical Antifungals Using a New Predictive Animal Model for Efficacy against Severe Tinea Unguium: A Comparison of Efinaconazole and Luliconazole

  2022cites this paper
• Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients

  2021cites this paper
• BIROn - Birkbeck Institutional Research Online as medicines: anti-fungal

  2021cites this paper
• A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model

  2021cites this paper
• A drug-in-adhesive anti-onychomycotic nail patch: influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.

  2021cites this paper
• A New In Vitro Model to Evaluate Anti-Adhesive Effect against Fungal Nail Infections

  2021cites this paper
• Design, Synthesis of Some New N-(2-fluoro-4-morpholin-4-yl-phenyl)-Substituted-Benzamide Derivatives and Screening of Their Microbial Activities

  2020cites this paper
• Evaluation of the Percutaneous Absorption of Drug Molecules in Zebrafish

  2020cites this paper
• FT-IR investigation of Terbinafine interaction with stratum Corneum constituents.

  2020cites this paper
• Development of an Animal Model of Onychomycosis in Guinea Pigs.

  2020cites this paper
• Onychomycosis in children – review on treatment and management strategies

  2020cites this paper
• Preparation, Characterisation, and Topical Delivery of Terbinafine

  2019cites this paper
• Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate

  2019cites this paper
• The efficacy and pharmacokinetics of terbinafine against the frog-killing fungus (Batrachochytrium dendrobatidis)

  2019cites this paper
• Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

  2018cites this paper
• Two strategies to enhance ungual drug permeation from UV‐cured films: Incomplete polymerisation to increase drug release and incorporation of chemical enhancers

  2018cites this paper
• New Topical Antifungals

  2017cites this paper
• Pathogenic Dermatophytes Survive in Nail Lesions During Oral Terbinafine Treatment for Tinea Unguium

  2017cites this paper
• An Assessment of In Vitro Antifungal Activities of Efinaconazole and Itraconazole against Common Non-Dermatophyte Fungi Causing Onychomycosis

  2017cites this paper
• Fungicidal Activity in the Presence of Keratin as an Important Factor Contributing to In Vivo Efficacy: A Comparison of Efinaconazole, Tavaborole, and Ciclopirox

  2017cites this paper
• Topical Onychomycosis Treatment Product Clenafin ® Topical Solution 10%

  2017cites this paper
• DDS製品開発の最前線 35 爪白癬治療薬クレナフィン爪外用液10

  2017cites this paper
• Relevant Animal Models in Dermatophyte Research

  2016cites this paper
• Progressive development in experimental models of transungual drug delivery of anti‐fungal agents

  2016cites this paper
• An investigation of how fungal infection influences drug penetration through onychomycosis patientâ€TMs nail plates

  2016cites this paper
• An investigation of how fungal infection influences drug penetration through onychomycosis patient’s nail plates

  2016cites this paper
• Hydroxychavicol: A phytochemical targeting cutaneous fungal infections

  2016cites this paper
• Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis

  2016cites this paper
• An investigation into UV-curable gel formulations for topical nail medicines

  2016influential citation
• Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.

  2016cites this paper
• UV-curable gels as topical nail medicines:In vivo residence, anti-fungal efficacy and influence of gel components on their properties.

  2016cites this paper
• Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success

  2015cites this paper
• Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.

  2015cites this paper
• Development of a novel in vitro onychomycosis model for the evaluation of topical antifungal activity.

  2015cites this paper
• New Topical Therapeutic Options in the Management of Superficial Fungal Infections.

  2015cites this paper
• La utilidad clínica de los derivados triazólicos en el tratamiento de las infecciones fúngicas

  2015cites this paper
• [Clinical usefulness of triazole derivatives in the management of fungal infections].

  2015cites this paper
• UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases.

  2015cites this paper
• The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

  2014cites this paper
• Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.

  2014cites this paper
• Efinaconazole 10% Nail Solution

  2014cites this paper
• In Vitro and In Vivo Assessment of Dermatophyte Acquired Resistance to Efinaconazole, a Novel Triazole Antifungal

  2014cites this paper
• Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.

  2014cites this paper
• Potential role of tavaborole for the treatment of onychomycosis.

  2014cites this paper
• The Low Keratin Affinity of Efinaconazole Contributes to Its Nail Penetration and Fungicidal Activity in Topical Onychomycosis Treatment

  2014influential citation
• The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

  2014cites this paper
• Focal Drug Delivery to the Nail

  2014cites this paper
• Animal Models as Tools for Translational Research: Focus on Dermatophytosis

  2013cites this paper
• Efinaconazole 10% solution: a new topical antifungal therapy for onychomycosis

  2013cites this paper
• Efinaconazole: First Global Approval

  2013cites this paper
• Comparison of In Vitro Antifungal Activities of Efinaconazole and Currently Available Antifungal Agents against a Variety of Pathogenic Fungi Associated with Onychomycosis

  2013cites this paper
• Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.

  2013cites this paper
• Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

  2013cites this paper
• Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent

  2013cites this paper
• Animal Model of Dermatophytosis

  2012cites this paper
• Animal Models of Human Pathology 2012

  2012cites this paper
• Establishment of a Novel Model of Onychomycosis in Rabbits for Evaluation of Antifungal Agents

  2011cites this paper
• Establishment of a novel model of onychomycosis in the rabbit

  2011cites this paper
• Dimethyl Sulfoxide ( DMSO ) has an Additive Effect and Alters Minimal Inhibitory Concentrations of Antifungal Drugs

  2011cites this paper
• [Antifungal agents for onychomycoses].

  2010cites this paper
• Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.

  2009cites this paper
• Trans-ungual iontophoretic delivery of terbinafine.

  2009cites this paper
• DETERMINATION OF THE PERMEABILITY OF BIOLOGICAL MEMBRANES TO VARIOUS CHEMICAL MARKERS, INCLUDING ANTI-HIV DRUGS

  2009cites this paper
• Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.

  2009cites this paper
• Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement.

  2009cites this paper
• Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.

  2009cites this paper
• In vitro Skin Permeability of Different Terbinafine Hydrochloride Formulations

  2008cites this paper
• Animal models: an important tool in mycology

  2007cites this paper
• Recent progress on the topical therapy of onychomycosis

  2007cites this paper
• Effect of Culture Medium on the Disk Diffusion Method for Determining Antifungal Susceptibilities of Dermatophytes

  2006cites this paper
• Ajoene, el principal compuesto activo derivado del ajo (Allium sativum), un nuevo agente antifúngico

  2006cites this paper
• [Ajoene the main active compound of garlic (Allium sativum): a new antifungal agent].

  2006cites this paper
• The effect of dimethyl sulfoxide (DMSO) on the growth of dermatophytes.

  2006cites this paper
• Progress on New Therapeuties for Fungal Nail Infections

  2005cites this paper
• Evaluation of Disk Diffusion Method for Determining Eberconazole Susceptibility of Dermatophytes and Influence of Culture Medium

  2005cites this paper
• [The pharmacokinetics of oral antifungal drugs and their efficacy against cutaneous mycosis].

  2005cites this paper
• Intracutaneous Distributions of Fluconazole, Itraconazole, and Griseofulvin in Guinea Pigs and Binding to Human Stratum Corneum

  2004cites this paper
• Infection and Drug Resistance Dovepress Efinaconazole in the Treatment of Onychomycosis

  year unknowncites this paper